Microbot Medical (MBOT) Debt to Equity (2016)
Microbot Medical's Debt to Equity history spans 7 years, with the latest figure at -$0.94 for Q3 2016.
- For the quarter ending Q3 2016, Debt to Equity fell 158.94% year-over-year to -$0.94, compared with a TTM value of -$0.94 through Sep 2016, down 158.94%, and an annual FY2015 reading of -$139.48, changed N/A over the prior year.
- Debt to Equity for Q3 2016 was -$0.94 at Microbot Medical, down from -$0.1 in the prior quarter.
- The five-year high for Debt to Equity was $17.53 in Q4 2014, with the low at -$139.48 in Q4 2015.
- Average Debt to Equity over 5 years is -$6.83, with a median of $0.16 recorded in 2012.
- Year-over-year, Debt to Equity soared 9050.48% in 2013 and then tumbled 1558.14% in 2014.
- Tracing MBOT's Debt to Equity over 5 years: stood at $0.02 in 2012, then soared by 2545.33% to $0.63 in 2013, then surged by 2697.15% to $17.53 in 2014, then tumbled by 895.81% to -$139.48 in 2015, then skyrocketed by 99.32% to -$0.94 in 2016.
- Per Business Quant, the three most recent readings for MBOT's Debt to Equity are -$0.94 (Q3 2016), -$0.1 (Q1 2016), and -$139.48 (Q4 2015).